Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.298 EUR | -12.87% | -4.49% | -27.32% |
15/05 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
30/04 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 2.57Cr 2.79Cr 232.96Cr | Sales 2023 | 3.22Cr 3.5Cr 291.89Cr | Capitalization | 2.56Cr 2.77Cr 231.59Cr |
---|---|---|---|---|---|
Net income 2022 | -4.4Cr -4.77Cr -398.25Cr | Net income 2023 | - 0 0 | EV / Sales 2022 | 3.59 x |
Net cash position 2022 | 48.75L 52.87L 44Cr | Net cash position 2023 | 19.34L 20.97L 18Cr | EV / Sales 2023 | 0.73 x |
P/E ratio 2022 |
-1.98
x | P/E ratio 2023 |
-40.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 32.4% |
Latest transcript on Biofrontera
1 day | -12.87% | ||
1 week | -4.49% | ||
Current month | -17.68% | ||
1 month | -11.83% | ||
3 months | -27.49% | ||
6 months | -34.65% | ||
Current year | -27.32% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 55 | 12/22/12 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 14/21/14 | |
Heikki Lanckriet
BRD | Director/Board Member | 46 | 14/21/14 |
Helge Lubenow
CHM | Chairman | 56 | 14/21/14 |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr | |
-0.45% | 16TCr |
- Stock Market
- Equities
- B8FK Stock
- B8F Stock